BRAF and nemaline myopathy: It is known that BRAF mutations are more common in NM [18] and that BRAF-positive patients survive longer than BRAF-negative patients [19], therefore BRAF status was also included in the new Melanoma-molGPA index published by Sperduto et al. [20].